Russell Investments Group
RUBY

Russell Investments Group’s Rubius Therapeutics, Inc RUBY Stock Holding History

Russell Investments Group’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,770
Closed -$64K – 2999
2022
Q1 		$64K Hold
11,770
– – ﹤0.01% 2613
2021
Q4 		$113K Hold
11,770
– – ﹤0.01% 2823
2021
Q3 		$210K Hold
11,770
– – ﹤0.01% 2760
2021
Q2 		$287K Hold
11,770
– – ﹤0.01% 2797
2021
Q1 		$311K Sell
11,770
-42,056
-78% -$614K ﹤0.01% 2701
2020
Q4 		$407K Sell
53,826
-26,676
-33% -$158K ﹤0.01% 2509
2020
Q3 		$402K Buy
80,502
+29,862
+59% +$158K ﹤0.01% 2490
2020
Q2 		$302K Sell
50,640
-96,895
-66% -$572K ﹤0.01% 2576
2020
Q1 		$656K Buy
+147,535
New +$1.1M ﹤0.01% 2056

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Russell Investments Group's RUBY Position: Q2 2022 in Review

Russell Investments Group sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2022, closing a stake of 11,770 shares — an estimated $64K sold.

Russell Investments Group first reported a position in RUBY in Q1 2020 and held it in 9 quarters. The position peaked at $656K in Q1 2020. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.

  • Russell Investments Group reported no remaining Rubius Therapeutics, Inc position as of Q2 2022 after selling out during the quarter.
  • Russell Investments Group sold 11,770 Rubius Therapeutics, Inc shares in Q2 2022, an estimated $64K.
  • Russell Investments Group first reported a position in Rubius Therapeutics, Inc in Q1 2020 and held it in 9 quarters.
  • Russell Investments Group's Rubius Therapeutics, Inc position peaked at $656K in Q1 2020.
  • 72 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2022.

Based on Russell Investments Group's 13F filing for Q2 2022, filed 29 Jul 2022.